Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dexmedetomidine × Ethanol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 4 Alcohol Drinking 4 Neoplasms 3 Pancreatic Cyst 2 Multiple Endocrine Neoplasia Type 1 2 Alcoholism 2 Warts 1 Torulopsis 1 Tobacco Use Disorder 1 Thyroid Nodule 1 Smoking Cessation 1 Smoking 1 Sexual Behavior 1 Papillomavirus Infections 1 Pancreatic Intraductal Neoplasms 1 Pain 1 Neuroblastoma 1 Neoplasms, Cystic, Mucinous, and Serous 1 Lymphoma 1 Lung Neoplasms 1 Leukoplakia, Oral 1 Leukemia 1 Homosexuality 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Fractures, Bone 1 Epidermodysplasia Verruciformis 1 Driving Under the Influence 1 Dexmedetomidine 1 Depression 1

Interventions

Dexmedetomidine 2 Saline Solution 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡